Canaccord Genuity revised its stock price target for Health Catalyst Inc. (NASDAQ:HCAT) shares, reducing it to $10 from the prior $11, while sustaining a Buy rating. According to InvestingPro data, ...

Linda Llewelyn, the Chief People Officer at Health Catalyst , Inc. (NASDAQ:HCAT), recently sold shares of the company, according to a filing with the Securities and Exchange Commission.

KeyCorp upgraded shares of Health Catalyst (NASDAQ:HCAT – Free Report) from a sector weight rating to an overweight rating in a report issued on Wednesday morning, MarketBeat Ratings reports.

Canaccord lowered the firm’s price target on Health Catalyst (HCAT) to $10 from $11 and keeps a Buy rating on the shares. The firm noted the ...

Catalyst Solutions, a leader in innovative health plan optimization, proudly announces its recognition as the Healthcare BPO of the Year by Healthcare Business Review. This is the third ...

He hatched Commure inside General Catalyst in 2017 alongside former leaders from Google, Salesforce, and healthcare data analytics firm Health Catalyst. In a Medium post announcing Commure's ...

SALT LAKE CITY, Jan. 30, 2025 (GLOBE NEWSWIRE) -- ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that ...

SALT LAKE CITY, Jan. 13, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations ...

SALT LAKE CITY, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare ...